The National Institute for Health and Care Excellence (NICE) is most well-known for its cost-effectiveness assessments of pharmaceutical goods and generation of clinical guidelines, which are used to guide health care reimbursement in England and Wales. Although the organization also provides guidance and assessments in the medtech field, this has historically taken a backseat to its other activities.
This may be set to change, as NICE’s chief executive Sam Roberts recently highlighted devices, diagnostics and digital as three...
